Neonatal Drug Therapy: The First Frontier of Therapeutics for Children

K Allegaert, John van den Anker

Research output: Contribution to journalArticleAcademicpeer-review

68 Citations (Scopus)


Knowledge about the safe and effective use of medicines in neonates has increased substantially but has resulted in few label changes. Drugs developed for use in adults are reshaped and tailored to specific neonatal indications. However, the use of drugs in neonates should not only mirror adult pharmacotherapy, but should be driven by their own specific needs. Therefore, building collaborative networks may assist to develop a newborn-driven research agenda addressing their clinical needs and diseases.
Original languageUndefined/Unknown
Pages (from-to)288-297
Number of pages10
JournalClinical Pharmacology & Therapeutics
Issue number3
Publication statusPublished - 2015

Cite this